EPIC and RX Healthcare Are Real Businesses, and EPIC'S AcuFAB(R) and Products Made From It Are Real
February 10 2014 - 9:00AM
Marketwired
EPIC and RX Healthcare Are Real Businesses, and EPIC'S AcuFAB(R)
and Products Made From It Are Real
AUSTIN, TX--(Marketwired - Feb 10, 2014) - EPIC Corporation
(PINKSHEETS: EPOR) ("EPIC"), and Ronald S. Tucker, EPIC's
president, announced "EPIC and its majority owned subsidiary RX
Healthcare Systems, Ltd., are in fact real businesses, and EPIC's
proprietary industrial and medical textile AcuFAB®, an
acupressure spacer fabric and the products from it for worldwide
consumer and healthcare market segments are facts. AcuFAB® provides
EPIC with a tangible asset in the equity value of RX Healthcare and
RX Healthcare with significant intrinsic value because the fabric
does what it is designed to do -- provide greater ventilation and
circulation when you need it."
Warren Buffett's and Charlie Munger's advise in making an
investment is to "look at the business first not the price, focus
on what is not when, determine value then look to price, have the
mindset of buying the whole business."
Mr. Tucker Stated:
EPIC is not a typical non-reporting pink sheet company. Both it
and RX Healthcare are real businesses with real products that do
what the products are supposed to do. For testimonials by consumers
and healthcare professionals please visit www.epiccor.us.
EPIC's goal in 2014 is the same as it was in 2013. The goal is
to define the type of company EPIC is, to monetize its intrinsic
value, to clearly set forth its value and show it is not your
ordinary penny stock company.
EPIC Corporation is a financial services company which provides
healthcare companies with corporate, business and financial
development services. RX Healthcare markets and distributes
healthcare and consumer products made from AcuFAB®.
EPIC seeks long term investors by demonstrating that it is
shareholder oriented, that it defines revenue as return on capital
and revenue growth is capital growth. It is not a development stage
company, but it is a business that builds development stage
healthcare companies through corporate, business and financial
services. For approximately 10 years EPIC has sought capital growth
through developing strategic relationships with independent third
party companies, but none of the companies presented met EPIC's
standards for revenue growth. More than five years ago EPIC
acquired a majority interest in RX Healthcare Systems, Inc., and,
in the last quarter of 2010, EPIC acquired rights to a proprietary
industrial and medical textile with a registered trade name of
AcuFAB.
EPIC, in 2013, monetized part of its intrinsic value in AcuFAB
by exchanging its rights in AcuFAB in a tax free exchange with a
non-affiliate European company which issued EPIC 1,500,000 shares
of its common stock a 27.27% interest in that company. The European
company then licensed the marketing and distribution rights to
North, Central, and South America to RX Healthcare for 3,000,000
euros, for which RX Health care issued the European Company
3,900,000 shares of its $1 face value Series A 5% Convertible
Preferred Stock.
EPIC, before September 30, 2013, had reported RX Healthcare on a
consolidated basis, but in the future it will be reported on an
equity basis. As a result in Q1 ending December 31, 2013, it will
have Net income of approximately $2.3 million from unrealized gain
in the equity of RX Healthcare.
EPIC's management, before the end of Q3, June 30, 2014,
anticipates the registration of a design patent for
AcuFAB® as an industrial and medical textile and the
engagement of a major US distributor for the distributions of
AcuFAB® products.
AcuFAB® enables EPIC through RX Healthcare to produce a
variety of products that can be sold in major market segments of
medical and consumer markets. It is EPIC's objective to realize
additional capital growth through the future revenue growth of RX
Healthcare and other companies. EPIC will receive cash flow by
suppling AcuFAB® to RX Healthcare and other companies.
AcuFAB® provides EPIC and RX Healthcare a unique
business model. Unique because neither is required to incur capital
costs for equipment or machinery and no factory overhead; there is
a single base fabric, used in multiple products, which is produced
by a textile mill capable of producing any quantity of the fabric
at a fixed cost; the production of the products made from the
fabric are at a fixed cost from a contract sewer capable of
producing any quantity of products; and there is minimal cost in
product development.
The only capital requirement is for RX Healthcare to pay for
marketing and advertising costs. EPIC is able to supply fabric from
inventory necessary to produce products for initial sales which
will generate the funds necessary for subsequent material
purchases.
Porter Stansberry wrote, "[When] a business reaches a certain
level of capital efficiency, the shares will soar over the long
run… The incredible thing is… no matter how big or small the
company is -- its shares almost always soar over the long
term."
EPIC management believes EPIC's stock is undervalued and is
positioned to soar.
To download EPIC's Statement of Information click the following
link:
https://dl.dropboxusercontent.com/u/71480488/Company%20and%20Product%20Info/2013%20Statement%20of%20Information%2012312013.pdf
To download EPIC's Annual Financial Statement click the
following link:
https://dl.dropboxusercontent.com/u/71480488/Company%20and%20Product%20Info/Financial%20Statements%209-30-2013.pdf
Visit www.epiccor.com for corporate information and
http://www.otcmarkets.com/stock/EPOR/quote for investor and
financial information.
CONTACT: Gregg Stachacz PR Director Email: Email Contact
Telephone: 904-282-3093
Epic (CE) (USOTC:EPOR)
Historical Stock Chart
From Jul 2024 to Aug 2024
Epic (CE) (USOTC:EPOR)
Historical Stock Chart
From Aug 2023 to Aug 2024